Table 1.

Baseline Demographic and Clinical Characteristics

Characteristic	Cy/GVAX Plus CRS-207 (n = 61)		Cy/GVAX (n = 29)		P
	No.	%	No.	%
Age, years					.9135
Median	63		67
Range	45-87		46-80
Sex					.3782
Male	34	56	19	66
Female	27	44	10	34
ECOG PS					.627
0	39	64	17	59
1	22	36	12	41
Site of metastasis					.5066
Liver	39	64	22	76
Lung only	14	23	4	14
Other	8	13	3	10
Disease status at study entry					.9102
Stable disease	12	20	6	21
Progressive disease	49	80	23	79
Any prior chemotherapy					N/A
Yes	59	97	28	97
No*	2	3	1	3
No. of prior chemotherapy treatments for metastatic disease					.7005
0	11	18	4	14
1	18	30	11	38
≥ 2	32	52	14	48
Previous surgical resection					.7383
Yes	23	38	12	41
No	38	62	17	59

Abbreviations: Cy, cyclophosphamide; ECOG PS, Eastern Cooperative Oncology Group performance status; N/A, not applicable.

^*Declined chemotherapy.